Cargando…

USP5 enhances SGTA mediated protein quality control

Mislocalised membrane proteins (MLPs) present a risk to the cell due to exposed hydrophobic amino acids which cause MLPs to aggregate. Previous studies identified SGTA as a key component of the machinery that regulates the quality control of MLPs. Overexpression of SGTA promotes deubiqutination of M...

Descripción completa

Detalles Bibliográficos
Autores principales: Hill, Jake, Nyathi, Yvonne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328565/
https://www.ncbi.nlm.nih.gov/pubmed/35895711
http://dx.doi.org/10.1371/journal.pone.0257786
_version_ 1784757749720023040
author Hill, Jake
Nyathi, Yvonne
author_facet Hill, Jake
Nyathi, Yvonne
author_sort Hill, Jake
collection PubMed
description Mislocalised membrane proteins (MLPs) present a risk to the cell due to exposed hydrophobic amino acids which cause MLPs to aggregate. Previous studies identified SGTA as a key component of the machinery that regulates the quality control of MLPs. Overexpression of SGTA promotes deubiqutination of MLPs resulting in their accumulation in cytosolic inclusions, suggesting SGTA acts in collaboration with deubiquitinating enzymes (DUBs) to exert these effects. However, the DUBs that play a role in this process have not been identified. In this study we have identified the ubiquitin specific peptidase 5 (USP5) as a DUB important in regulating the quality control of MLPs. We show that USP5 is in complex with SGTA, and this association is increased in the presence of an MLP. Overexpression of SGTA results in an increase in steady-state levels of MLPs suggesting a delay in proteasomal degradation of substrates. However, our results show that this effect is strongly dependent on the presence of USP5. We find that in the absence of USP5, the ability of SGTA to increase the steady state levels of MLPs is compromised. Moreover, knockdown of USP5 results in a reduction in the steady state levels of MLPs, while overexpression of USP5 increases the steady state levels. Our findings suggest that the interaction of SGTA with USP5 enables specific MLPs to escape proteasomal degradation allowing selective modulation of MLP quality control. These findings progress our understanding of aggregate formation, a hallmark in a range of neurodegenerative diseases and type II diabetes, as well as physiological processes of aggregate clearance.
format Online
Article
Text
id pubmed-9328565
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-93285652022-07-28 USP5 enhances SGTA mediated protein quality control Hill, Jake Nyathi, Yvonne PLoS One Research Article Mislocalised membrane proteins (MLPs) present a risk to the cell due to exposed hydrophobic amino acids which cause MLPs to aggregate. Previous studies identified SGTA as a key component of the machinery that regulates the quality control of MLPs. Overexpression of SGTA promotes deubiqutination of MLPs resulting in their accumulation in cytosolic inclusions, suggesting SGTA acts in collaboration with deubiquitinating enzymes (DUBs) to exert these effects. However, the DUBs that play a role in this process have not been identified. In this study we have identified the ubiquitin specific peptidase 5 (USP5) as a DUB important in regulating the quality control of MLPs. We show that USP5 is in complex with SGTA, and this association is increased in the presence of an MLP. Overexpression of SGTA results in an increase in steady-state levels of MLPs suggesting a delay in proteasomal degradation of substrates. However, our results show that this effect is strongly dependent on the presence of USP5. We find that in the absence of USP5, the ability of SGTA to increase the steady state levels of MLPs is compromised. Moreover, knockdown of USP5 results in a reduction in the steady state levels of MLPs, while overexpression of USP5 increases the steady state levels. Our findings suggest that the interaction of SGTA with USP5 enables specific MLPs to escape proteasomal degradation allowing selective modulation of MLP quality control. These findings progress our understanding of aggregate formation, a hallmark in a range of neurodegenerative diseases and type II diabetes, as well as physiological processes of aggregate clearance. Public Library of Science 2022-07-27 /pmc/articles/PMC9328565/ /pubmed/35895711 http://dx.doi.org/10.1371/journal.pone.0257786 Text en © 2022 Hill, Nyathi https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Hill, Jake
Nyathi, Yvonne
USP5 enhances SGTA mediated protein quality control
title USP5 enhances SGTA mediated protein quality control
title_full USP5 enhances SGTA mediated protein quality control
title_fullStr USP5 enhances SGTA mediated protein quality control
title_full_unstemmed USP5 enhances SGTA mediated protein quality control
title_short USP5 enhances SGTA mediated protein quality control
title_sort usp5 enhances sgta mediated protein quality control
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328565/
https://www.ncbi.nlm.nih.gov/pubmed/35895711
http://dx.doi.org/10.1371/journal.pone.0257786
work_keys_str_mv AT hilljake usp5enhancessgtamediatedproteinqualitycontrol
AT nyathiyvonne usp5enhancessgtamediatedproteinqualitycontrol